Innovative EUR250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi

25-11-2021 08:46 | 1 jaar geleden Economie

Dit is een origineel bericht van
PR Newswire

BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant on September 10, 2021. JUMPstart is an initiative that aims to nurture research in the field of parenteral nutrition through the mentoring, education and networking of clinicians and researchers. The grant is awarded to help to advance novel, community-led research in parenteral nutrition, to make a difference for critically ill patients.

This year's winner is Professor Stefan Schaller M.D. of Charité - Universitätsmedizin Berlin, Germany, for his proposal entitled "Improved muscle metabolism by combination of muscle activation and protein substitution." This cutting-edge study aims to explore the effect of protein substitution before and after early, goal-directed mobilization in the acute phase of critical illness. The announcement was made at the European Society for Clinical Nutrition and Metabolism (ESPEN) Congress.

During the virtual awards ceremony, Professor Schaller said: "After working on this research proposal for a long time, me and my research team are thrilled to be able to now conduct the study, and I am very thankful to the generous grant from Fresenius Kabi. I am very optimistic that this trial will have an impact on nutrition therapy in critical care."

Professor Schaller took part in the program alongside 18 other participants from around the world, including representation from Africa, Asia, Australia, Europe, New Zealand, and North and South America. After four training sessions, participants presented their research proposals to an independent international scientific committee, which consisted of five field-leading experts: Professor Mette Berger, Switzerland; Professor Olav Rooyackers, Sweden; Professor Tim Friede, Germany; Professor Robert Martindale, USA; and Professor Ho-Seong Han, South Korea. The committee was impressed by the high-quality level of all proposals, and this made picking a winner extremely challenging.

Dr. Jos Simons, Executive Vice President at Fresenius Kabi, commented: "We are absolutely delighted to be able to award this research grant to Professor Schaller. Both the scientific committee and Fresenius Kabi were astounded by his proposal and the positive impact it will have on clinical practice. We are very excited for Professor Schaller to start this clinical study."

This is the second JUMPstart research grant worth EUR250,000. The first program of 19 participants completed in 2019, with the grant awarded to dietician Lizl Veldsman, Tygerberg Academic Hospital in Cape Town, South Africa.

With the JUMPstart education program and research grant, Fresenius Kabi supports the next generation of clinical experts who will contribute to advancement in nutrition therapy in critically ill patients.

Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company's products and services are used to help care for critically and chronically ill patients. Fresenius Kabi's product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.

With its corporate philosophy of "caring for life", the company is committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face.

Fresenius Kabi employs around 40,500 people worldwide. In 2020, the company reported sales of around EUR7.0 billion. Fresenius Kabi AG is a wholly owned subsidiary of the Fresenius SE & Co. KGaA healthcare group.

For more information, please visit

This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius Kabi does not undertake any responsibility to update the forward-looking statements in this release.

Management Board: Michael Sen (Chairman), Marc Crouton, John Ducker, Dr. Oskar Haszonits, Dr. Christian Hauer, Dr. Michael Schönhofen, Gerrit Steen

Chairman of the Supervisory Board: Stephan Sturm

Registered Office: Bad Homburg, Germany

Commercial Register: Amtsgericht Bad Homburg - HRB 11654

Emese Kamp PINK CARROTS Communications GmbH E-mail: Phone: +49 69 4272614-141

Photo - Logo - ]

Web site:

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Andere persberichten van deze organisatie

Life Electric: GWM Brazil brand launch & HAVAL H6 PHEV 4WD World Premiere

BAODING, China, Nov. 26, 2022 /PRNewswire/ -- On November 23, at the Museum of Tomorrow in Rio, GWM launched its brand and world premier of its HAVAL H6 PHEV 4WD. GWM Brazil will offer with cleaner and smarter solutions, as a NEV pioneer in the fast growing Latin American market. Dubbed a theme of "Tomorrow is ON", GWM introduced its brand vision, smart electric tech and business plan to hundreds of media and investors at the event. GWM's global
1 uur geleden

Liminal BioSciences kondigt speciale aandeelhoudersvergadering aan

LAVAL, QC en CAMBRIDGE, Engeland, 26 november 2022 /PRNewswire/ -- Liminal BioSciences Inc. ("Liminal BioSciences" of het "bedrijf"), heeft aangekondigd dat het op 20 januari 2023 een virtuele speciale aandeelhoudersvergadering zal houden om goedkeuring te vragen voor de wijziging van de statuten van het bedrijf ter uitvoering van een consolidatie van alle uitgegeven en uitstaande gewone aandelen van het bedrijf ("gewone aandelen") op basis van e
7 uur geleden


A New World Unfolds with the First 48V Powerpack GUNSKIRCHEN, Austria, Nov. 25, 2022 /PRNewswire/ -- BRP Inc. is proud to announce the launch of a new e-powertrain, the Rotax E10, bolstering its electric offering for karting. The new product was presented today at the Rotax MAX Challenge (RMC) Grand Finals in Portimao, Portugal, where the international RMC karting community was gathered. With the all-new E10 48V high performance racing electric p
14 uur geleden

Floating on Cloud Nine: Emma Transforms Ferris Wheel Carriage into a Bedroom

-- Emma is giving away free rides in its Cloud Nine capsule this weekend, which soars over 200 feet above the Austrian capital -- Visitors have the chance to enjoy spectacular views over Vienna from the comfort of a bed VIENNA, Nov. 25, 2022 /PRNewswire/ -- Float on Cloud Nine this weekend with a free ride in Emma's dedicated sleep capsule on the Vienna Giant Ferris Wheel, available from today until Sunday. The Giant Ferris Wheel in the Vienna Pr
14 uur geleden

Opening of Zuunbayan-Khangi railway set to deliver major boost to Mongolian exports and economy

ULAANBAATAR, Mongolia, Nov. 25, 2022 /PRNewswire/ -- The Prime Minister of Mongolia, L. Oyun-Erdene, has today opened a major new rail link which will provide a significant boost to the country's export competitiveness and wider economy as part of the Government's 'New Recovery Policy'. The Zuunbayan-Khangi railway, which runs for 226.9km across south eastern Mongolia, provides a vital connection between the Tavantolgoi-Zuunbayan railway and the
17 uur geleden

Upcoming China-Central and Eastern European Countries International Trade Digital Expo shows China's effort in promoting international trade

BEIJING, Nov. 25, 2022 /PRNewswire/ -- China-Central and Eastern European Countries International Trade Digital Expo will be held on the online platform-Fast Expo ( from 28 Nov. to 7 Dec. 2022. It's hosted by China Council for the Promotion of International Trade (CCPIT) and co-organized by China Chamber of International Commerce, CCPIT Information Center and CMEC International Exhibition Co., Ltd. The Digital Expo aims t
18 uur geleden